Systematic review of cancer presentations with a median survival of six months or less.

Summary: When cancer reaches a critical, advanced stage, patients and doctors face heart-wrenching decisions. A massive review of 383 studies looked at patients with a predicted survival of six months or less. The findings reveal a consistent pattern: regardless of the cancer type, signs like significant weight loss, fatigue, and spreading disease mark a point of no return. Crucially, the review found that at this specific terminal stage, aggressive treatments generally do not extend life. Instead, they often increase suffering through toxic side effects. This suggests that for these patients, the focus should shift from fighting the disease to prioritizing comfort and quality of life.